Concerns arise over the integrity of data used by regulators, with claims of manipulation and bias in reporting adverse effects. The discussion highlights troubling cases of myocarditis linked to vaccinations, where investigations into deaths remain incomplete or pending. The lack of thorough examination raises questions about accountability and the role of pharmaceutical companies in self-regulation.
